Journal of Parkinsons Disease

Papers
(The TQCC of Journal of Parkinsons Disease is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
This is NOT the End for Immunotherapy in Parkinson’s Disease – A Perspective from Early Drug Development Scientists115
Clinical Trial Highlights: Modulators of Mitochondrial Function92
Introduction: The Earliest Phase of Parkinson’s Disease: Possibilities for Detection and Intervention74
Chronotropic Incompetence in Parkinson’s Disease: A Possible Marker of Severe Disease Phenotype?61
One-year practice effects predict long-term cognitive outcomes in Parkinson's disease60
Parkinson’s Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson’s Disease Progression58
A framework to standardize gait study protocols in Parkinson's disease56
A Multisensory Deficit in the Perception of Pleasantness in Parkinson’s Disease52
Are Preformed Fibrils a Model of Parkinson’s Disease?50
May Bradykinesia Features Aid in Distinguishing Parkinson’s Disease, Essential Tremor, And Healthy Elderly Individuals?48
Cost-Effectiveness and Cost-Utility of Early Levodopa in Parkinson’s Disease47
Ethical Considerations for Identifying Individuals in the Prodromal/Early Phase of Parkinson’s Disease: A Narrative Review46
Imaging Biomarkers in Prodromal and Earliest Phases of Parkinson’s Disease46
Jellinger K, “Parkinson’s Disease and Dementia with Lewy Bodies: One and the Same”45
Post-Traumatic Stress Disorder and Risk of Parkinson’s Disease in a Veteran Cohort44
Effects of Very Low- and High-Frequency Subthalamic Stimulation on Motor Cortical Oscillations During Rhythmic Lower-Limb Movements in Parkinson’s Disease Patients43
Reply to the Letter to the Editor: Stefani A, “Is it too early to Underrate Genetic onto PD Pathogenesis? Reflections on History”43
Evading the Immune System: Immune Modulation and Immune Matching in Cell Replacement Therapies for Parkinson’s Disease42
Atrophy-related corticospinal changes in advanced Parkinson's disease are associated with the genetic etiology of the disease42
Rapid Voluntary Blinking as a Clinical Marker of Parkinson’s Disease41
Apathy Reflects Extra-Striatal Dopaminergic Degeneration in de novo Parkinson’s Disease40
Glucocerebrosidase Activity is Reduced in Cryopreserved Parkinson’s Disease Patient Monocytes and Inversely Correlates with Motor Severity40
No Higher Risk-Seeking Tendencies or Altered Self-Estimation in a Social Decision-Making Task in Patients with Parkinson’s Disease40
Cerebral Small Vessel Disease Is Associated with Motor, Cognitive, and Emotional Dysfunction in Multiple System Atrophy38
The fixel GI Parkinson's research and integrated support model (PRISM)38
Current Update on Clinically Relevant Sleep Issues in Parkinson’s Disease: A Narrative Review37
Real-World Evaluation of the Feasibility, Acceptability and Safety of a Remote, Self-Management Parkinson’s Disease Care Pathway: A Healthcare Improvement Initiative37
Blood and Cerebrospinal Fluid Biomarkers of Inflammation in Parkinson’s Disease37
A possible pathway to freezing of gait in Parkinson's disease37
Early-Onset Parkinson’s Disease: Creating the Right Environment for a Genetic Disorder36
Predictive Value of Verbatim Parkinson’s Disease Patient-Reported Symptoms of Postural Instability and Falling35
Clinical Trial Highlights – Aerobic Exercise for Parkinson’s Disease35
Is There an Association Between Parkinson’s Disease and Periodontitis? A Systematic Review and Meta-Analysis35
The Role of Microelectrode Recording and Stereotactic Computed Tomography in Verifying Lead Placement During Awake MRI-Guided Subthalamic Nucleus Deep Brain Stimulation for Parkinson’s Disease34
Metabotropic Glutamate Receptor 4 (mGlu4) Positive Allosteric Modulators Lack Efficacy in Rat and Marmoset Models of L-DOPA-Induced Dyskinesia34
A Coalition to Advance Treatments for Parkinson’s Disease, Dementia with Lewy Bodies, and Related Disorders34
Association of Dynamic Changes in Metabolic Syndrome Status with the Risk of Parkinson’s Disease: A Nationwide Cohort Study33
Burden of tremor in Parkinson's disease: A survey study33
The Compound ATH434 Prevents Alpha-Synuclein Toxicity in a Murine Model of Multiple System Atrophy32
The Role of Diet in Parkinson’s Disease31
Surveying Global Availability of Parkinson’s Disease Treatment31
Feasibility and Proof-of-Concept of Delivering an Autonomous Music-Based Digital Walking Intervention to Persons with Parkinson’s Disease in a Naturalistic Setting30
Modulation of Cerebellar Oscillations with Subthalamic Stimulation in Patients with Parkinson’s Disease30
Nomogram to Predict the Probability of Functional Dependence in Early Parkinson’s Disease30
Nigral Iron Deposition Influences Disease Severity by Modulating the Effect of Parkinson’s Disease on Brain Networks30
Deficient Interhemispheric Connectivity Underlies Movement Irregularities in Parkinson’s Disease29
Metabolic connectivity of freezing in Parkinson's disease29
Burden, Anxiety, and Depression Among Caregivers of Parkinson’s Disease Patients29
Nomogram for Early Prediction of Parkinson’s Disease Based on microRNA Profiles and Clinical Variables29
Mortality and causes of death in patients with Parkinson's disease in Taiwan28
Localized Pantothenic Acid (Vitamin B5) Reductions Present Throughout the Dementia with Lewy Bodies Brain28
Mild cognitive impairment is not predictive of dementia up to 15 years after subthalamic deep brain stimulation in Parkinson's disease28
Taste Impairments in a Parkinson’s Disease Model Featuring Intranasal Rotenone Administration in Mice27
Sex-Related Longitudinal Change of Motor, Non-Motor, and Biological Features in Early Parkinson’s Disease27
The Human Hippocampus in Parkinson’s Disease: An Integrative Stereological and Proteomic Study26
Neuroinflammation and Immune Changes in Prodromal Parkinson’s Disease and Other Synucleinopathies26
Gene Therapy to Modulate Alpha-Synuclein in Synucleinopathies26
DNA Methylation Signature of Aging: Potential Impact on the Pathogenesis of Parkinson’s Disease25
Twenty-five-year experience with apomorphine pump in Parkinson's disease: A real-life long-term retrospective tolerance study25
Acknowledgment to Reviewers 202224
Do Impulse Control Disorders Impair Car Driving Performance in Patients with Parkinson’s Disease?24
Neuropsychiatric Burden Is a Predictor of Early Freezing and Motor Progression in Drug-Naïve Parkinson’s Disease24
Blood Cholesterol Decreases as Parkinson’s Disease Develops and Progresses23
Hidden Gems in Neurology: The Syndrome of Hemiparkinsonism-Hemiatrophy23
Bringing Advanced Therapies for Parkinson’s Disease to the Clinic: The Scientist’s Perspective23
Symmetric and Profound Monoaminergic Degeneration in Parkinson’s Disease with Premotor REM Sleep Behavior Disorder22
Gait Declines Differentially in, and Improves Prediction of, People with Parkinson’s Disease Converting to a Freezing of Gait Phenotype22
Locus Coeruleus Degeneration Correlated with Levodopa Resistance in Parkinson’s Disease: A Retrospective Analysis22
A Summary of Phenotypes Observed in the In Vivo Rodent Alpha-Synuclein Preformed Fibril Model21
Effects of Low-Intensity Vestibular Noise Stimulation on Postural Instability in Patients with Parkinson’s Disease21
Motor Memory Consolidation Deficits in Parkinson’s Disease: A Systematic Review with Meta-Analysis21
Recruitment for Remote Decentralized Studies in Parkinson’s Disease21
Effects of 6 months of endurance exercise on motor function, exercise capacity, and autonomic function based on presence of autonomic dysfunction in individuals with early Parkinson's disease21
Specific Detection of Physiological S129 Phosphorylated α-Synuclein in Tissue Using Proximity Ligation Assay20
Barriers to Vaccination Among People with Parkinson’s Disease and Implications for COVID-1920
Multiple Pathways of LRRK2-G2019S/Rab10 Interaction in Dopaminergic Neurons20
Prevalence of Prodromal Symptoms of Parkinson’s Disease in the Late Middle-Aged Population20
Non-Pharmacological Interventions for People with Parkinson’s Disease: Are We Entering a New Era?19
Enhancing Trial Delivery in Parkinson’s Disease: Qualitative Insights from PD STAT19
Structural-Functional Correlates of Response to Pedunculopontine Stimulation in a Randomized Clinical Trial for Axial Symptoms of Parkinson’s Disease19
Unveiling the neural network of freezing of gait in Parkinson's disease: A coordinate-based network study19
Enhancing Participant Engagement in Clinical Studies: Strategies Applied in the Personalized Parkinson Project18
Subcortical Iron Accumulation Pattern May Predict Neuropsychological Outcomes After Subthalamic Nucleus Deep Brain Stimulation: A Pilot Study18
Enhancing the diagnostic potential of electroretinography in Parkinson's disease: A review of protocol and cohort criteria18
“Tip-of-the-Tongue” Phenomenon in Parkinson’s Disease: A Hidden Gem18
Tackling Parkinson’s Disease as a Global Challenge18
Validating a Seated Virtual Reality Threat Paradigm for Inducing Anxiety and Freezing of Gait in Parkinson’s Disease18
Parkinson’s Pals: A Student-Led Program to Facilitate Intergenerational Connections and Promote Psychosocial Well-Being Among Persons with Parkinson’s Disease18
Evaluating the Psychometric Properties of the Psychological Capital Questionnaire (PCQ) in Patients with Parkinson’s Disease18
Self-Reported Visual Complaints in People with Parkinson’s Disease: A Systematic Review18
Freezing of gait detection: The effect of sensor type, position, activities, datasets, and machine learning model17
Parkinson’s Disease and the Gut: Symptoms, Nutrition, and Microbiota17
Disease-Modifying Therapies for Multiple System Atrophy: Where Are We in 2022?17
Integrating virtual reality into multidisciplinary care for Parkinson's disease: A narrative review17
Specialized Allied Health Care for Parkinson’s Disease: State of the Art and Future Directions17
The Utility of Breath Analysis in the Diagnosis and Staging of Parkinson’s Disease17
Incretin Mimetics Restore the ER-Mitochondrial Axis and Switch Cell Fate Towards Survival in LUHMES Dopaminergic-Like Neurons: Implications for Novel Therapeutic Strategies in Parkinson’s Disease17
Staging Parkinson’s Disease According to the MNCD (Motor/Non-motor/Cognition/Dependency) Classification Correlates with Disease Severity and Quality of Life16
Sex-specific progression of Parkinson's disease: A longitudinal mixed-models analysis16
Anxiety-related attentional characteristics and their relation to freezing of gait in people with Parkinson's: Cross-validation of the Adapted Gait Specific Attentional Profile (G-SAP)16
Neurodegeneration of the Globus Pallidus Internus as a Neural Correlate to Dopa-Response in Freezing of Gait16
Neuroticism, Smoking, and the Risk of Parkinson’s Disease16
A Practical Guide to the Evaluation of Compensation Strategies for Gait Impairment in Parkinson’s Disease16
Alterations in Self-Aggregating Neuropeptides in Cerebrospinal Fluid of Patients with Parkinsonian Disorders16
40-Year Incidence of Early-Onset Parkinson’s Disease in Southeast Minnesota16
Utility of a newly created questionnaire on subtle motor symptoms in high-risk subjects with Parkinson's disease16
Designing the First Trials for Parkinson’s Prevention16
Kinematic Effects of Combined Subthalamic and Dorsolateral Nigral Deep Brain Stimulation in Parkinson’s Disease16
Feasibility and acceptability of PDConnect, a multi-component intervention to support physical activity in people with Parkinson's disease: A mixed methods study16
Non-Motor Features of Parkinson’s Disease in Women15
Discontinuation or acute unplanned cessation of oral dopaminergic medications in persons with Parkinson's disease: A practice review15
Anxiety in Parkinson’s Disease Is Associated with Changes in Brain Structural Connectivity15
Non-Pharmacological Treatment of Autonomic Dysfunction in Parkinson’s Disease and Other Synucleinopathies15
Tetrabenazine Mitigates Aberrant Release and Clearance of Dopamine in the Nigrostriatal System, and Alleviates L-DOPA-Induced Dyskinesia in a Mouse Model of Parkinson’s Disease15
Reduced Thickness of the Retina in de novo Parkinson’s Disease Shows A Distinct Pattern, Different from Glaucoma15
Which Neuropsychological Tests? Predicting Cognitive Decline and Dementia in Parkinson’s Disease in the ICICLE-PD Cohort15
Fatigue in de novo Parkinson’s Disease: Expanding the Neuropsychiatric Triad?14
Can People with Parkinson’s Disease Self-Trigger Gait Initiation? A Comparison of Cueing Strategies14
Emerging Role of Environmental Epitranscriptomics and RNA Modifications in Parkinson’s Disease14
Trichloroethylene: An Invisible Cause of Parkinson’s Disease?14
Bringing Advanced Therapy Medicinal Products (ATMPs) for Parkinson’s Disease to the Clinic: The Investigator’s Perspective14
Neuroimaging Correlates of Substantia Nigra Hyperechogenicity in Parkinson’s Disease14
Advice to People with Parkinson’s in My Clinic: Orthostatic Hypotension14
Unmet needs in the pharmacological management of motor symptoms in Parkinson's disease14
Quantitative Susceptibility Mapping and Free Water Imaging of Substantia Nigra in Parkinson’s Disease14
Gender Distribution in Deep Brain Stimulation for Parkinson’s Disease: The Effect of Awake versus Asleep Surgery14
Prevalence of Concomitant Pathologies in Parkinson’s Disease: Implications for Prognosis, Diagnosis, and Insights into Common Pathogenic Mechanisms14
Intestinal biomarkers, microbiota composition, and genetic predisposition to inflammatory bowel disease as predictors of Parkinson's disease manifestation14
Serum Neurofilament Dynamics Predicts Cognitive Progression in de novo Parkinson’s Disease14
Remote Delivery of Allied Health Therapies in Parkinson’s Disease14
Distinct Patterns of Gene Expression Changes in the Colon and Striatum of Young Mice Overexpressing Alpha-Synuclein Support Parkinson’s Disease as a Multi-System Process14
Association Between Body Mass Index Changes and All-Cause Mortality in Parkinson’s Disease13
Exploring the link between personality dimensions and non-motor fluctuations in Parkinson's disease13
Mycobacterium bovis Infection of a Deep Brain Stimulation System Following Intravesical Bacillus Calmette-Guérin (BCG) Instillation13
Self-Perception of Voice and Swallowing Handicap in Parkinson’s Disease13
New insights from a Malaysian real-world deep brain stimulation cohort13
Return on Investment Analysis for the Integrated Parkinson’s Care Network: Lesson Learned from a Pilot Study13
RAGE Against the Glycation Machine in Synucleinopathies: Time to Explore New Questions13
Natural Health Products for Symptomatic Relief of Parkinson’s Disease: Prevalence, Interest, and Awareness13
Non-Motor Symptom Management: Insights into Adherence to Treatment Guidelines in Parkinson’s Disease Patients13
Spinal Cord Stimulation for Gait Disorders in Parkinson’s Disease13
Immunological Features of LRRK2 Function and Its Role in the Gut-Brain Axis Governing Parkinson’s Disease13
Assessing the Role of Locus Coeruleus Degeneration in Essential Tremor and Parkinson’s Disease with Sleep Disorders13
Proposed mechanisms of neuroprotection for nicotine in Parkinson's disease13
Inflammasome Activation in Parkinson’s Disease13
Diffuse putaminal degeneration without iron deposition in multiple system atrophy13
Pediatric-onset PRKN disease: New insights into an understudied population13
Biofluid Detection of Pathological α-Synuclein in the Prodromal Phase of Synucleinopathies13
Axial Impairment Following Deep Brain Stimulation in Parkinson’s Disease: A Surgicogenomic Approach13
Longitudinal Cohort Study of Verbatim-Reported Postural Instability Symptoms as Outcomes for Online Parkinson’s Disease Trials13
PTEN-Induced Putative Kinase 1 Dysfunction Accelerates Synucleinopathy12
Risk of Neurodegeneration in Patients with Rapid Eye Movement Sleep Behavior Disorder12
The potential of distributed diagnostics for the early detection of Parkinson's disease12
The Use of Image Guided Programming to Improve Deep Brain Stimulation Workflows with Directional Leads in Parkinson’s Disease12
Pain Fluctuations in Parkinson’s Disease and Their Association with Motor and Non-Motor Fluctuations12
Infections and Changes in Commensal Bacteria and the Pathogenesis of Parkinson’s Disease12
Letter to the Editor: Is It Too Early to Underrate Genetics onto PD Pathogenesis? Reflections on History12
Therapeutic Strategies for Immune Transformation in Parkinson’s Disease12
Non-Pharmacological Interventions for Depression and Anxiety in Parkinson’s Disease12
Constipation Predicts Cognitive Decline in Parkinson’s Disease: Results from the COPPADIS Cohort at 2-Year Follow-up and Comparison with a Control Group12
Depressive symptoms can negatively influence patient reported disease severity after subthalamic nucleus stimulation for Parkinson's disease12
Appropriateness of Applying Cerebrospinal Fluid Biomarker Cutoffs from Alzheimer’s Disease to Parkinson’s Disease12
Acknowledgment to Reviewers 202312
Glucocerebrosidase Mutations and Motor Reserve in Parkinson’s Disease12
The Role of Pathogens and Anti-Infective Agents in Parkinson’s Disease, from Etiology to Therapeutic Implications12
Impaired Inhibitory Control During Walking in Parkinson’s Disease Patients: An EEG Study12
Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2021 Update12
Mapping Cholinergic Synaptic Loss in Parkinson’s Disease: An [18F]FEOBV PET Case-Control Study12
How Information Affects Patients with Parkinson’s Disease: A Scoping Review of the Literature12
Efficacy of Istradefylline, an Adenosine A2A Receptor Antagonist, as Adjunctive Therapy to Levodopa in Parkinson’s Disease: A Pooled Analysis of 8 Phase 2b/3 Trials11
Diffusion MRI Captures White Matter Microstructure Alterations in PRKN Disease11
Modeling of Parkinson’s Disease Progression and Implications for Detection of Disease Modification in Treatment Trials11
Increasing trends in utilization of physical and occupational therapy services in early Parkinson's disease11
Oscillation-Specific Nodal Differences in Parkinson’s Disease Patients with Anxiety11
Motor outcomes in unilateral, bilateral rapid, and bilateral delayed staging deep brain stimulation for Parkinson’s disease11
Structural Connectivity of Subthalamic Nucleus Stimulation for Improving Freezing of Gait11
Disease Progression of Data-Driven Subtypes of Parkinson’s Disease: 5-Year Longitudinal Study from the Early Parkinson’s Disease Longitudinal Singapore (PALS) Cohort11
Dopaminergic Cell Replacement for Parkinson’s Disease: Addressing the Intracranial Delivery Hurdle11
Hypomimia May Influence the Facial Emotion Recognition Ability in Patients with Parkinson’s Disease11
Personality Changes After Subthalamic Nucleus Stimulation in Parkinson’s Disease11
Worsening of Parkinson’s Disease After Termination of COVID-19 Quarantine Cannot Be Reversed Despite Resumption of Physiotherapy11
Development of a Screening Tool for Assessing Sexual Difficulties Among Patients with Parkinson’s Disease: The PD-SDS11
Colonoscopy and Subsequent Risk of Parkinson’s Disease11
Characterization of Depressive and Anxiety Symptoms in Idiopathic REM Sleep Behavior Disorder11
Preparing for Parkinson’s disease prevention trials: Current progress and future directions11
Machine Learning-Based Classification of Parkinson’s Disease Patients Using Speech Biomarkers11
Integration of Virtual Reality into Transcranial Magnetic Stimulation Improves Cognitive Function in Patients with Parkinson’s Disease with Cognitive Impairment: A Proof-of-Concept Study11
Why the Gut Microbiome Must Be Considered When Evaluating the Impact of Pesticides on Parkinson’s Disease Risk11
Comparative Analysis of Total Alpha-Synuclein (αSYN) Immunoassays Reveals That They Do Not Capture the Diversity of Modified αSYN Proteoforms11
Retrograde Procedural Memory in Parkinson’s Disease: A Cross-Sectional, Case-Control Study11
Insights on Genetic and Environmental Factors in Parkinson’s Disease from a Regional Swedish Case-Control Cohort11
0.1213710308075